Investors Research Corp’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$316K Sell
2,341
-2,009
-46% -$354K 0.06% 212
2026
Q1
$781K Sell
4,350
-740
-15% -$126K 0.15% 128
2025
Q4
$720K Sell
5,090
-1,450
-22% -$165K 0.13% 144
2025
Q3
$530K Hold
6,540
0.1% 192
2025
Q2
$410K Hold
6,540
0.08% 219
2025
Q1
$471K Hold
6,540
0.1% 196
2024
Q4
$563K Hold
6,540
0.12% 180
2024
Q3
$619K Buy
6,540
+70
+1% +$6.21K 0.14% 177
2024
Q2
$618K Hold
6,470
0.14% 175
2024
Q1
$852K Buy
+6,470
New +$797K 0.2% 123

Other funds holding ALB

Investors Research Corp's ALB Position: Q2 2026 in Review

Investors Research Corp reduced its Albemarle (ALB) stake by 46% in Q2 2026, selling an estimated $354K and leaving 2,341 shares worth $316K. The position accounts for 0.06% of the portfolio, ranked #212.

Investors Research Corp first reported a position in ALB in Q1 2024 and has held it in 10 quarters since. The position peaked at $852K in Q1 2024. 169 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

  • Investors Research Corp held 2,341 shares of Albemarle worth $316K as of Q2 2026.
  • Investors Research Corp sold 2,009 Albemarle shares in Q2 2026, an estimated $354K.
  • Albemarle made up 0.06% of Investors Research Corp's portfolio in Q2 2026, its #212 holding.
  • Investors Research Corp first reported a position in Albemarle in Q1 2024 and has held it in 10 quarters since.
  • Investors Research Corp's Albemarle position peaked at $852K in Q1 2024.
  • 169 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on Investors Research Corp's 13F filing for Q2 2026, filed 10 Jul 2026.